|
|
Article: Data from Baylor College of Medicine, College of Medicine provide new insights into heparin.
- Article from:
- Biotech Week
- Article date:
- June 10, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"We sought to determine the safety and efficacy of enoxaparin versus unfractionated heparin during percutaneous coronary intervention (PCI). Four hundred ninety-three consecutive patients undergoing elective or emergency PCI received unflactionated heparin (70 U/kg, intravenously) or enoxaparin (1 mg/kg, intravenously)," scientists in the United States report (see also Heparin).
"Patients who had received subcutaneous enoxaparin in the emergency department were given a supplementary 0.3-mg/kg intravenous dose. There was no crossover of therapies. All patients received oral antiplatelet therapy and eptifibatide. Primary safety outcomes were bleeding and a ...
Related newspaper, magazine, and journal articles:
|
|
Article: Hospitals Partner in Waco, Texas' Baylor College of ...
Knight Ridder/Tribune Business News;
April 23, 2004 ;
700+ words
... ... primary teaching hospital for Baylor College of Medicine. "For someone ... and president of the Texas Heart Institute, its research arm, and ... next month at the Texas Heart Institute will feature DeBakey as ... 1962 to found the Texas Heart Institute, acknowledging that ...
|
|